Trial intelligence / Profile preview

IPT with DP for malaria in Ugandan school children

NCT01231880Phase 3Completed

Sponsor
Makerere University
Start
Feb 2011
Primary completion
Sep 2012
Modality
Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of dihydroartemisinin + piperaquine in malaria, sponsored by Makerere University. Started Feb 2011; status: completed.

02

Drugs

dihydroartemisinin + piperaquine
03

Conditions

malaria

Beyond the preview

Go deeper on NCT01231880.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01231880.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call